HealthTree Research

Our HealthTree Research events help you learn about the latest research and studies related to your cancer, including interviews with medical specialists.

Upcoming Events Past Events

Episode 3: Young Adult AML: Understanding the Gaps & Closing Them

May 05, 2025

May 05, 2025 / 12:00PM EDT

Adult AML Chapter

Episode 2: Fighting AML in Young Patients: New Research & the Future of CAR-T

Apr 28, 2025

Apr 28, 2025 / 12:00PM EDT

Adult AML Chapter

Episode 1: When Should Treatment Start? What AML Patients Need to Know

Apr 21, 2025

Apr 21, 2025 / 12:00PM EDT

Adult AML Chapter

How HealthTree is Investing in Cures

Dec 11, 2024

Dec 11, 2024 / 05:00PM - 06:00PM EST

Menin Inhibitors 101 with Dr. Joshua Zeidner

Jul 09, 2024

Jul 09, 2024 / 05:00PM EDT

Adult AML Chapter

Reducing Relapse Risk After Transplant Using Jakafi With Gabriela Hobbs, MD, Massachusetts General Hospital

Oct 05, 2022

Oct 05, 2022 / 01:30PM EDT

HealthTree Podcast for AML

Expanding the Use of Ivosidenib (Tibsovo) In Newly Approved Combination For IDH1-Mutated AML with Eytan Stein, MD, Memorial Sloan Kettering

Aug 24, 2022

Aug 24, 2022 / 11:00AM EDT

HealthTree Podcast for AML

Working to Overcome Health Disparities in AML

Mar 30, 2022

Mar 30, 2022 / 04:00PM - 05:00PM EDT

Adult AML Chapter

AML Progress in 2021 and a Look to the Future with Dr. Eytan Stein

Feb 02, 2022

Feb 02, 2022 / 12:00PM EST

HealthTree Podcast for AML

HealthTree Research

Episode 3: Young Adult AML: Understanding the Gaps & Closing Them

Episode 2: Fighting AML in Young Patients: New Research & the Future of CAR-T

Episode 1: When Should Treatment Start? What AML Patients Need to Know

How HealthTree is Investing in Cures

Menin Inhibitors 101 with Dr. Joshua Zeidner

Reducing Relapse Risk After Transplant Using Jakafi With Gabriela Hobbs, MD, Massachusetts General Hospital

Expanding the Use of Ivosidenib (Tibsovo) In Newly Approved Combination For IDH1-Mutated AML with Eytan Stein, MD, Memorial Sloan Kettering

Working to Overcome Health Disparities in AML

AML Progress in 2021 and a Look to the Future with Dr. Eytan Stein

Trending Articles

Menin Inhibitors: A New Treatment Option for Acute Leukemia Patients

What Works Better for AML: Intensive Chemotherapy or Venetoclax/HMAs?

Understanding the Timing of Treatment in Acute Myeloid Leukemia (AML)

Which CAR-T is the Best for You? Comparing Cilta-cel and Ide-cel

Understanding Cancer Cachexia and Its Impact on AML Survival

Education

Community

Cure Hub

Get Involved

About us

Need Help?

Legal Info

Follow Us

HealthTree Research

Episode 3: Young Adult AML: Understanding the Gaps & Closing Them

Episode 2: Fighting AML in Young Patients: New Research & the Future of CAR-T

Episode 1: When Should Treatment Start? What AML Patients Need to Know

How HealthTree is Investing in Cures

Menin Inhibitors 101 with Dr. Joshua Zeidner

Reducing Relapse Risk After Transplant Using Jakafi With Gabriela Hobbs, MD, Massachusetts General Hospital

Expanding the Use of Ivosidenib (Tibsovo) In Newly Approved Combination For IDH1-Mutated AML with Eytan Stein, MD, Memorial Sloan Kettering

Working to Overcome Health Disparities in AML

AML Progress in 2021 and a Look to the Future with Dr. Eytan Stein

Trending Articles

Menin Inhibitors: A New Treatment Option for Acute Leukemia Patients

What Works Better for AML: Intensive Chemotherapy or Venetoclax/HMAs?

Understanding the Timing of Treatment in Acute Myeloid Leukemia (AML)

Which CAR-T is the Best for You? Comparing Cilta-cel and Ide-cel

Understanding Cancer Cachexia and Its Impact on AML Survival

Get the Latest Chronic Lymphocytic Leukemia Updates, Delivered to You.

Education

Community

Cure Hub

Get Involved

About us

Need Help?

Legal Info

Follow Us